These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3583430)

  • 1. Preservation of peritoneal clearance.
    Wu GG; Oreopoulos DG
    Int J Artif Organs; 1987 Mar; 10(2):67-71. PubMed ID: 3583430
    [No Abstract]   [Full Text] [Related]  

  • 2. [The introduction to continuous ambulatory peritoneal dialysis (CAPD)].
    Sanaka T; Ikehara O
    Nihon Rinsho; 2004 May; 62 Suppl 5():269-74. PubMed ID: 15197928
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of acetate in loss of ultrafiltration during CAPD.
    Rottembourg J; Brouard R; Issad B; Allouache M; Ghali B; Boudjemaa A
    Contrib Nephrol; 1987; 57():197-206. PubMed ID: 3677694
    [No Abstract]   [Full Text] [Related]  

  • 4. [The quality of the peritoneum in continuous ambulatory peritoneal dialysis].
    Krediet RT; Boeschoten EW; Arisz L
    Ned Tijdschr Geneeskd; 1986 Jan; 130(3):110-3. PubMed ID: 3951598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Encapsulating peritonitis during continuous ambulatory peritoneal dialysis. A physiopathologic hypothesis].
    Verger C; Celicout B; Larpent L; Goupil A
    Presse Med; 1986 Sep; 15(28):1311-4. PubMed ID: 2950390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology of the peritoneum in CAPD.
    Dobbie JW
    Blood Purif; 1989; 7(2-3):74-85. PubMed ID: 2663038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
    Ti JP; Al-Aradi A; Conlon PJ; Lee MJ; Morrin MM
    AJR Am J Roentgenol; 2010 Jul; 195(1):W50-4. PubMed ID: 20566781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal fungal peritonitis by Trichoderma longibrachiatum complicating peritoneal dialysis.
    Tanis BC; van der Pijl H; van Ogtrop ML; Kibbelaar RE; Chang PC
    Nephrol Dial Transplant; 1995; 10(1):114-6. PubMed ID: 7724005
    [No Abstract]   [Full Text] [Related]  

  • 10. [Icodextrin as first treatment: reasons to be optimistic].
    Rivera M
    Nefrologia; 2009; 29(2):99-102. PubMed ID: 19396313
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal ultrastructure and changes with continuous ambulatory peritoneal dialysis.
    Dobbie JW
    Perit Dial Int; 1993; 13 Suppl 2():S585-7. PubMed ID: 8399672
    [No Abstract]   [Full Text] [Related]  

  • 13. Sclerosing peritonitis complicating continuous ambulatory peritoneal dialysis with the use of chlorhexidine in alcohol.
    Lo WK; Chan KT; Leung AC; Pang SW; Tse CY
    Adv Perit Dial; 1990; 6():79-84. PubMed ID: 1982846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerosing encapsulating peritonitis in children.
    Niaudet P; Berard E; Revillon Y; Lothon M; Broyer M
    Contrib Nephrol; 1987; 57():230-8. PubMed ID: 3677698
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 17. Case report of encapsulating peritoneal sclerosis: the interpretation of functional and structural peritoneal changes.
    Diaz-Buxo JA
    Blood Purif; 2008; 26(1):12-7. PubMed ID: 18182789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems in the surgical management of sclerosing encapsulating peritonitis.
    Assalia A; Schein M; Hashmonai M
    Isr J Med Sci; 1993 Nov; 29(11):686-8. PubMed ID: 8270396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Yang LY; Chen A; Huang TP
    Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerosing peritonitis.
    Bowers VD; Ackermann JR; Richardson W; Carey LC
    Clin Transplant; 1994 Aug; 8(4):369-72. PubMed ID: 7949541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.